<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22899429</PMID><DateCompleted><Year>2013</Year><Month>01</Month><Day>03</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1995-820X</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>4</Issue><PubDate><Year>2012</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Virologica Sinica</Title><ISOAbbreviation>Virol Sin</ISOAbbreviation></Journal><ArticleTitle>Replication kinetics of coxsackievirus A16 in human rhabdomyosarcoma cells.</ArticleTitle><Pagination><StartPage>221</StartPage><EndPage>227</EndPage><MedlinePgn>221-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12250-012-3245-x</ELocationID><Abstract><AbstractText>Coxsackievirus A16 (CVA16), together with enterovirus type 71 (EV71), is responsible for most cases of hand, foot and mouth disease (HFMD) worldwide. Recent findings suggest that the recombination between CVA16 and EV71, and the co-circulation of these two viruses may have contributed to the increase of HFMD cases in China over the past few years. It is therefore important to further understand the virology, epidemiology, virus-host interactions and host pathogenesis of CVA16. In this study, we describe the viral kinetics of CVA16 in human rhabdomyosarcoma (RD) cells by analyzing the cytopathic effect (CPE), viral RNA replication, viral protein expression, viral RNA package and viral particle secretion in RD cells. We show that CVA16 appears to first attach, uncoat and enter into the host cell after adsorption for 1 h. Later on, CVA16 undergoes rapid replication from 3 to 6 h at MOI 1 and until 9 h at MOI 0.1. At MOI 0.1, CVA16 initiates a secondary infection as the virions were secreted before 9 h p.i. CPE was observed after 12 h p.i., and viral antigen was first detected at 6 h p.i. at MOI 1 and at 9 h p.i. at MOI 0.1. Thus, our study provides important information for further investigation of CVA16 in order to better understand and ultimately control infections with this virus.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>National Engineering Laboratory for AIDS Vaccine, College of Life Science, Jilin University, Changchun, 130012, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Mingming</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Lin</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>An</LastName><ForeName>Dong</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Kong</LastName><ForeName>Wei</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Chunlai</ForeName><Initials>C</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>07</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Virol Sin</MedlineTA><NlmUniqueID>101514185</NlmUniqueID><ISSNLinking>1995-820X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003588" MajorTopicYN="N">Cytopathogenic Effect, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000254" MajorTopicYN="N">growth &amp; development</QualifierName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019065" MajorTopicYN="N">Virus Assembly</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014776" MajorTopicYN="N">Virus Cultivation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053586" MajorTopicYN="N">Virus Internalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057074" MajorTopicYN="N">Virus Release</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>6</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>1</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2013</Year><Month>7</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22899429</ArticleId><ArticleId IdType="pmc">PMC8218092</ArticleId><ArticleId IdType="doi">10.1007/s12250-012-3245-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ang L. W., Koh B. K., Chan K. P., et al. Epidemiology and control of hand, foot and mouth disease in Singapore, 2001&#x2013;2007. Ann Acad Med Singapore. 2009;38(2):106&#x2013;112.</Citation><ArticleIdList><ArticleId IdType="pubmed">19271036</ArticleId></ArticleIdList></Reference><Reference><Citation>Baccam P., Beauchemin C., Macken C. A., et al. Kinetics of influenza A virus infection in humans. J Virol. 2006;80(15):7590&#x2013;7599. doi: 10.1128/JVI.01623-05.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01623-05</ArticleId><ArticleId IdType="pmc">PMC1563736</ArticleId><ArticleId IdType="pubmed">16840338</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardosa M. J., Perera D., Brown B. A., et al. Molecular epidemiology of human enterovirus 71 strains and recent outbreaks in the Asia-Pacific region: comparative analysis of the VP1 and VP4 genes. Emerg Infect Dis. 2003;9(4):461&#x2013;468.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2957976</ArticleId><ArticleId IdType="pubmed">12702227</ArticleId></ArticleIdList></Reference><Reference><Citation>Chun T. W., Carruth L., Finzi D., et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature. 1997;387(6629):183&#x2013;188. doi: 10.1038/387183a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/387183a0</ArticleId><ArticleId IdType="pubmed">9144289</ArticleId></ArticleIdList></Reference><Reference><Citation>Cromeans T., Fields H. A., Sobsey M. D. Replication kinetics and cytopathic effect of hepatitis A virus. J Gen Virol. 1989;70(Pt8):2051&#x2013;2062. doi: 10.1099/0022-1317-70-8-2051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-70-8-2051</ArticleId><ArticleId IdType="pubmed">2549182</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger D., Bienz K. Intracellular location and translocation of silent and active poliovirus replication complexes. J Gen Virol. 2005;86(Pt3):707&#x2013;718. doi: 10.1099/vir.0.80442-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.80442-0</ArticleId><ArticleId IdType="pubmed">15722531</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia P. M., Kalish L. A., Pitt J., et al. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N Engl J Med. 1999;341(6):394&#x2013;402. doi: 10.1056/NEJM199908053410602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199908053410602</ArticleId><ArticleId IdType="pubmed">10432324</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadinoto V., Shapiro M., Sun C. C., et al. The dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral output. PLoS Pathog. 2009;5(7):e1000496. doi: 10.1371/journal.ppat.1000496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000496</ArticleId><ArticleId IdType="pmc">PMC2698984</ArticleId><ArticleId IdType="pubmed">19578433</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollingsworth T D, Laeyendecker O, Shirreff G, et al. HIV-1 transmitting couples have similar viral load set-points in Rakai, Uganda. PLoS Pathog, 6(5):e1000876.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2865511</ArticleId><ArticleId IdType="pubmed">20463808</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosoya M., Kawasaki Y., Sato M., et al. Genetic diversity of coxsackievirus A16 associated with hand, foot, and mouth disease epidemics in Japan from 1983 to 2003. J Clin Microbiol. 2007;45(1):112&#x2013;120. doi: 10.1128/JCM.00718-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00718-06</ArticleId><ArticleId IdType="pmc">PMC1828949</ArticleId><ArticleId IdType="pubmed">17093028</ArticleId></ArticleIdList></Reference><Reference><Citation>Jabs D. A., Gilpin A. M., Min Y. I., et al. HIV and cytomegalovirus viral load and clinical outcomes in AIDS and cytomegalovirus retinitis patients: Monoclonal Antibody Cytomegalovirus Retinitis Trial. AIDS. 2002;16(6):877&#x2013;887. doi: 10.1097/00002030-200204120-00007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00002030-200204120-00007</ArticleId><ArticleId IdType="pubmed">11919489</ArticleId></ArticleIdList></Reference><Reference><Citation>Kung Y H, Huang S W, Kuo P H, et al. Introduction of a strong temperature-sensitive phenotype into enterovirus 71 by altering an amino acid of virus 3D polymerase. Virology, 396(1):1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">19906393</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin K. H., Hwang K. P., Ke G. M., et al. Evolution of EV71 genogroup in Taiwan from 1998 to 2005: an emerging of subgenogroup C4 of EV71. J Med Virol. 2006;78(2):254&#x2013;262. doi: 10.1002/jmv.20534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.20534</ArticleId><ArticleId IdType="pubmed">16372302</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J, He M L, Wang L, et al. MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2. Cancer Res, 71(1):225&#x2013;233.</Citation><ArticleIdList><ArticleId IdType="pubmed">21199804</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J, He Y Q, Yi L N, et al. Viral kinetics of enterovirus 71 in human abdomyosarcoma cells. World J Gastroenterol, 17(36):4135&#x2013;4142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3203367</ArticleId><ArticleId IdType="pubmed">22039330</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyles R. H., Munoz A., Yamashita T. E., et al. Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study. J Infect Dis. 2000;181(3):872&#x2013;880.</Citation><ArticleIdList><ArticleId IdType="pubmed">10720507</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y., Yu J., Chan H. L., et al. Glucose-regulated protein 78 is an intracellular antiviral factor against hepatitis B virus. Mol Cell Proteomics. 2009;8(11):2582&#x2013;2594. doi: 10.1074/mcp.M900180-MCP200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/mcp.M900180-MCP200</ArticleId><ArticleId IdType="pmc">PMC2773723</ArticleId><ArticleId IdType="pubmed">19671925</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn P. C. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev. 2002;26(1):91&#x2013;107. doi: 10.1111/j.1574-6976.2002.tb00601.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-6976.2002.tb00601.x</ArticleId><ArticleId IdType="pubmed">12007645</ArticleId></ArticleIdList></Reference><Reference><Citation>Mellors J. W., Munoz A., Giorgi J. V., et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med. 1997;126(12):946&#x2013;954.</Citation><ArticleIdList><ArticleId IdType="pubmed">9182471</ArticleId></ArticleIdList></Reference><Reference><Citation>Muir P., Kammerer U., Korn K., et al. Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis. Clin Microbiol Rev. 1998;11(1):202&#x2013;227.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC121380</ArticleId><ArticleId IdType="pubmed">9457433</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann A. U., Lam N. P., Dahari H., et al. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science. 1998;282(5386):103&#x2013;107. doi: 10.1126/science.282.5386.103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.282.5386.103</ArticleId><ArticleId IdType="pubmed">9756471</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijhuis M., van Maarseveen N., Schuurman R., et al. Rapid and sensitive routine detection of all members of the genus enterovirus in different clinical specimens by real-time PCR. J Clin Microbiol. 2002;40(10):3666&#x2013;3670. doi: 10.1128/JCM.40.10.3666-3670.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.40.10.3666-3670.2002</ArticleId><ArticleId IdType="pmc">PMC130891</ArticleId><ArticleId IdType="pubmed">12354863</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y., Shimojima M., Tano Y., et al. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med. 2009;15(7):794&#x2013;797. doi: 10.1038/nm.1961.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1961</ArticleId><ArticleId IdType="pubmed">19543284</ArticleId></ArticleIdList></Reference><Reference><Citation>Perelson A. S., Neumann A. U., Markowitz M., et al. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science. 1996;271(5255):1582&#x2013;1586. doi: 10.1126/science.271.5255.1582.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.271.5255.1582</ArticleId><ArticleId IdType="pubmed">8599114</ArticleId></ArticleIdList></Reference><Reference><Citation>Podin Y., Gias E. L., Ong F., et al. Sentinel surveillance for human enterovirus 71 in Sarawak, Malaysia: lessons from the first 7 years. BMC Public Health. 2006;6:180. doi: 10.1186/1471-2458-6-180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2458-6-180</ArticleId><ArticleId IdType="pmc">PMC1543637</ArticleId><ArticleId IdType="pubmed">16827926</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabenau H F, Richter M, Doerr H W. Hand, foot and mouth disease: seroprevalence of Coxsackie A16 and Enterovirus 71 in Germany. Med Microbiol Immunol, 199(1):45&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">19941005</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribeiro R. M., Lo A., Perelson A. S. Dynamics of hepatitis B virus infection. Microbes Infect. 2002;4(8):829&#x2013;835. doi: 10.1016/S1286-4579(02)01603-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1286-4579(02)01603-9</ArticleId><ArticleId IdType="pubmed">12270730</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T, Lewthwaite P, Perera D, et al. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis, (11):778&#x2013;790.</Citation><ArticleIdList><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S., Yamashita Y., Li J., et al. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med. 2009;15(7):798&#x2013;801. doi: 10.1038/nm.1992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1992</ArticleId><ArticleId IdType="pubmed">19543282</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi L, He Y, Chen Y, et al. Potent inhibition of human enterovirus 71 replication by type I interferon subtypes. Antivir Ther, 16(1):51&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">21311108</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas D. L., Villano S. A., Riester K. A., et al. Perinatal transmission of hepatitis C virus from human immunodeficiency virus type 1-infected mothers. Women and Infants Transmission Study. J Infect Dis. 1998;177(6):1480&#x2013;1488. doi: 10.1086/515315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/515315</ArticleId><ArticleId IdType="pubmed">9607823</ArticleId></ArticleIdList></Reference><Reference><Citation>Yip C C, Lau S K, Zhou B, et al. Emergence of enterovirus 71 &#x201c;double-recombinant&#x201d; strains belonging to a novel genotype D originating from southern China: first evidence for combination of intratypic and intertypic recombination events in EV71. Arch Virol, 155(9):1413&#x2013;1424.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7087135</ArticleId><ArticleId IdType="pubmed">20549263</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H. M., Li C. R., Liu Y. J., et al. To investigate pathogen of hand, foot and mouth disease in Shenzhen in 2008. Chin J Exp Clin Virol. 2009;23(5):334&#x2013;336.</Citation><ArticleIdList><ArticleId IdType="pubmed">20387478</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Zhu Z, Yang W, et al. An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China. Virol J, 7:94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2885340</ArticleId><ArticleId IdType="pubmed">20459851</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoll J., Heus H. A., van Kuppeveld F. J., et al. The structure-function relationship of the enterovirus 3&#x2032;-UTR. Virus Res. 2009;139(2):209&#x2013;216. doi: 10.1016/j.virusres.2008.07.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2008.07.014</ArticleId><ArticleId IdType="pubmed">18706945</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>